Related Experiment Video
Updated: Mar 9, 2026

Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
Citrate pathophysiology and metabolism
1Intensive care deparment, Centre Hospitalier de Melun, Melun, F-77000, France.
Insights
Citrate anticoagulation effectively prevents bleeding during extracorporeal circuits by chelating calcium. However, it can cause hypocalcemia, leading to QT prolongation and hypotension, especially in patients with cirrhosis.
Area of Science:
- Nephrology
- Hematology
- Critical Care Medicine
Background:
- Citrate anticoagulation is a widely used method in extracorporeal circuits, offering an alternative to heparin.
- It functions by chelating ionized calcium, thereby inhibiting the coagulation cascade.
- Citrate anticoagulation is associated with reduced activation of leukocytes and platelets.
Purpose of the Study:
- To evaluate the efficacy and safety of citrate anticoagulation in extracorporeal circuits.
- To investigate the impact of citrate on patient anticoagulation and bleeding risk.
- To explore the metabolic fate and potential toxic effects of citrate, particularly in patients with renal impairment or liver cirrhosis.
Main Methods:
- Review of existing literature on citrate anticoagulation in extracorporeal circuits.
- Analysis of citrate pharmacokinetics and its clearance mechanisms, including the citric acid cycle (Krebs cycle).
- Examination of citrate's effects on ionized calcium levels, coagulation parameters, and potential adverse events like hypocalcemia and QT interval prolongation.
Main Results:
- Citrate effectively achieves anticoagulation in extracorporeal circuits without increasing the patient's bleeding risk.
- Citrate anticoagulation demonstrates a reduced activation of leukocytes and platelets compared to other anticoagulation methods.
- Citrate clearance via the citric acid cycle is unaffected by renal failure but is significantly reduced (by approximately 50%) in patients with cirrhosis.
- Toxic citrate effects are primarily linked to a decrease in plasma ionized calcium, with clinical signs of hypocalcemia and hypotension observed below 0.9 mmol/L.
Conclusions:
- Citrate anticoagulation is a safe and effective method for extracorporeal circuits, minimizing bleeding complications.
- Patient factors, particularly liver cirrhosis, can significantly impair citrate metabolism, increasing the risk of toxicity.
- Close monitoring of ionized calcium levels is crucial to prevent adverse events such as QT prolongation and hypotension in patients undergoing citrate anticoagulation.
Abstract:
By chelating ionized calcium, citrate allows extracorporeal circuit anticoagulation without a bleeding risk for the patient. Citrate anticoagulation is also associated with a reduced activation of leucocytes and platelets. Citrate clearance by citric acid cycle (Krebs cycle) is not modified by renal failure, but is reduced by about 50% in patients with cirrhosis. Toxic effects of citrate result from a decrease in plasma ionized calcium of the patient. The first side effect is a prolongation of the QT interval. Clinical signs of hypocalcemia and hypotension in humans appear below 0.9mmol/L of plasma ionized calcium.
Related Concept Videos
The Citric Acid Cycle: Output
Regulation of Citric Acid Cycle
The citric acid cycle is regulated in several ways, including feedback inhibition, regulation of enzyme activities, and associated anaplerotic or cataplerotic pathways.
The primary substrate of the TCA cycle—acetyl CoA—is...
The Citric Acid Cycle: Overview
The citric...
The Citric Acid Cycle
Products of the Citric Acid Cycle
Respiration Pathways
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

